Efficacy and Tolerability of Controlled-Release Paroxetine
By Robert N. Golden, MD
Artículo original
Estudio de validación de la Escala de Salud Personal (ESP) en Lima, Perú
Dra. María Isabel Zapata-Vega, Dr. Juan Enrique Mezzich, Dr. Guido Mazzotti, Dr. Robert De la Grecca, Dr. Jean-Pierre Llanos y Dra. Juana Hernández
EVIDENCE-BASED MEDICINE
A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders
By Patricia Berney, Demian Halperin, Rodrigo Tango, Isabelle Daeniker-Dayer, Pierre Schulz
Treatment of Autism Spectrum Disorder in Children and Adolescents
By Melissa DeFilippis, Karen Dineen Wagner
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
By Christoph U. Correll, Richard C. Josiassen, Grace S. Liang, Joshua Burke, Christopher F. O’Brien
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
By John M. Kane, Christoph U. Correll, Grace S. Liang, Joshua Burke, Christopher F. O’Brien
A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
By Robert Risinger, Marjie Hard, Peter J. Weiden